Metal implants may cut chemotherapy side effects, study suggests

Scientists have developed modified chemotherapy drugs that are designed to remain inactive until they come into contact with a palladium implant located at the tumor site. The hope is that this approach could help to reduce the side effects associated with treatment by minimizing damage to the rest of the body. Credit: Asier Unciti-Broceta

Cancer patients could one day experience fewer side effects from chemotherapy following a discovery that opens the door for more targeted treatments.

Researchers have identified a possible way of treating tumours that would see doctors place harmless metal implants at the cancer site.

The discovery could make treatment more targeted than existing therapies, avoiding unwanted side effects, such as , tiredness and nausea. These occur when carried in the blood kill healthy cells as well as .

The scientists found that they could alter the chemical composition of commonly used drugs so that they only become active when they come into contact with a metal called palladium.

Researchers hope that by implanting small devices coated with palladium into patients' tumours, the drugs would become activated only where they are needed, causing minimal damage to the rest of the body.

The scientists reported their discovery today in the journal Nature Communications but the approach will first need to be tested in animals before it can be studied in patients.

The research was led by scientists from the Edinburgh Cancer Research UK Centre at the MRC Institute of Genetics and Molecular Medicine, the University of Edinburgh.

Dr Asier Unciti-Broceta, who led the study, said: "It will be several years before we're able to start treating patients but we're hopeful that this approach will lead to better tolerated cancer therapies in the future."

Related Stories

Classification system for bladder cancer prognosis

Jan 29, 2014

Researchers at Lund University have developed a classification system to determine the prognosis for bladder cancer. It is hoped that this will prove useful for future bladder cancer research and drug development.

Researchers discover new combination therapy to kill cancer

Jan 27, 2014

Cancer is the leading cause of death in Canada and is responsible for about 30% of all deaths, according to the Canadian Cancer Society. Despite the urgent need for new and effective drugs, it remains extremely difficult ...

Double dose of genes can trigger poor cancer survival

Jan 23, 2014

(Medical Xpress)—Cancer Research UK scientists have shown that accidental DNA doubling in bowel cancer cells could predict which patients have potentially poor survival and help doctors plan their treatment, ...

Recommended for you

Why we should vaccinate boys against HPV as well as girls

22 minutes ago

Gillian Prue, from the School of Nursing and Midwifery at Queen's University of Belfast, says that the human papillomavirus (HPV) infection is common in men and can lead to genital warts and the development of some head and ...

Generation of tanners see spike in deadly melanoma

12 hours ago

(AP)—Stop sunbathing and using indoor tanning beds, the acting U.S. surgeon general warned in a report released Tuesday that cites an alarming 200 percent jump in deadly melanoma cases since 1973.

Penn team makes cancer glow to improve surgical outcomes

12 hours ago

The best way to cure most cases of cancer is to surgically remove the tumor. The Achilles heel of this approach, however, is that the surgeon may fail to extract the entire tumor, leading to a local recurrence.

User comments